GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pak Fah Yeow International Ltd (HKSE:00239) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Pak Fah Yeow International (HKSE:00239) Future 3-5Y EPS without NRI Growth Rate : N/A (As of May. 28, 2025)


View and export this data going back to 1991. Start your Free Trial

What is Pak Fah Yeow International Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Pak Fah Yeow International's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of Pak Fah Yeow International's Future 3-5Y EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Pak Fah Yeow International's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pak Fah Yeow International's Future 3-5Y EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pak Fah Yeow International's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Pak Fah Yeow International's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

Pak Fah Yeow International  (HKSE:00239) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Pak Fah Yeow International Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Pak Fah Yeow International's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Pak Fah Yeow International Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pak Fah Yeow International Ltd (HKSE:00239) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Comparable Companies
HKSE:03737 HKSE:00950 HKSE:03839 HKSE:00897 HKSE:00455 HKSE:01011 HKSE:01652 HKSE:08329 HKSE:08049 HKSE:00575 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
200 Gloucester Road, 11th Floor, Wanchai, Hong Kong, HKG
Website
https://www.pakfahyeow.com
Pak Fah Yeow International Ltd, with its subsidiaries, is engaged in the manufacture and distribution of healthcare products, including Hoe Hin branded products. It also engages in real estate investment and treasury investment businesses. It has three business segments, namely healthcare, property investments, and treasury investments. The Company derives the majority of its revenues from the Healthcare segment.
Executives
Gan Fock Wai Stephen 2101 Beneficial owner
Brooke Jonathan William 2101 Beneficial owner

Pak Fah Yeow International Headlines

No Headlines